Gupta, Arti, Rajan, Vishnu, Aravindakshan, Rajeev et al. · Cureus · 2025 · DOI
This study looked at 500 COVID-19 survivors in rural India to see how many developed chronic fatigue syndrome (CFS)—a condition causing severe, lasting tiredness and other symptoms. About 21% of the COVID-19 survivors developed CFS, with older people, women, and those with existing health conditions at higher risk. The study found that fatigue, joint pain, and muscle pain were common problems after COVID-19.
This study documents the substantial burden of post-COVID fatigue in an underrepresented population (rural India), highlighting that ME/CFS-like conditions are not confined to high-income settings. Identifying high-risk groups (elderly, female, comorbid patients) helps clinicians prioritize post-COVID monitoring and enables resource-limited healthcare systems to plan targeted interventions for long COVID sequelae.
This cross-sectional design cannot establish causation or mechanisms underlying CFS development after COVID-19—it only documents associations. The study does not clarify whether observed fatigue meets strict ME/CFS diagnostic criteria (e.g., post-exertional malaise), and the lack of association with vaccination does not prove vaccination is irrelevant to post-COVID outcomes in other contexts. The retrospective methodology may introduce recall bias and selection bias in symptom reporting.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →